Histamine H2 receptor negatively regulates oligodendrocyte differentiation in neonatal hypoxic-ischemic white matter injury.
Histamine H2 receptor negatively regulates oligodendrocyte differentiation in neonatal hypoxic-ischemic white matter injury.
复制标题
组胺 H2 受体负向调节新生儿缺氧缺血性白质损伤中的少突胶质细胞分化。
DOI:
10.1084/jem.20191365
复制
发表时间:
2021-01-04
期刊:
影响因子:
--
通讯作者:
Chen Z
中科院分区:
文献类型:
--
作者:
Jiang L;Cheng L;Chen H;Dai H;An D;Ma Q;Zheng Y;Zhang X;Hu W;Chen Z
This study demonstrated that histamine H2 receptor in oligodendrocytes negatively regulates its differentiation and remyelination in neonatal hypoxic-ischemic white matter injury through acting on the Wnt/β-catenin signaling pathway. The H2 receptor antagonists may have potential therapeutic value for neonatal hypoxic-ischemic encephalopathy. Neonatal hypoxic-ischemic encephalopathy (HIE) with the pathological characteristic of white matter injury often leads to lifelong cognitive and neurobehavioral dysfunction, but relevant therapies to promote remyelination are still unavailable. We found that histamine H2 receptor (H2R) negatively regulated the oligodendrocyte differentiation rate without affecting the oligodendrocytes at the oligodendrocyte precursor cell stage or mature stage following oxygen-glucose deprivation in vitro. Notably, selective deletion of the H2R gene (Hrh2) in differentiating oligodendrocytes (Hrh2fl/fl;CNPase-Cre) improved their differentiation, remyelination, and functional recovery following neonatal hypoxia-ischemia in mice. The regulation of oligodendrocyte differentiation by H2R is mediated by binding with Axin2, which leads to up-regulation of the Wnt/β-catenin signaling pathway. Furthermore, H2R antagonists also promoted oligodendrocyte differentiation and remyelination and the recovery of cognition and motor functions following neonatal hypoxia-ischemia. Thus, histamine H2R in oligodendrocytes could serve as a novel and effective therapeutic target for the retard of oligodendrocyte differentiation and remyelination following neonatal hypoxia-ischemia. The H2R antagonists may have potential therapeutic value for neonatal HIE.
登录
查看更多内容
影响因子:
56.9
作者:
Behrens, J;Jerchow, BA;Birchmeier, W
通讯作者:
Birchmeier, W
影响因子:
9.2
作者:
Hart, MJ;de los Santos, R;Polakis, P
通讯作者:
Polakis, P
影响因子:
14.5
作者:
Cree, Bruce A. C.;Niu, Jianqin;Fancy, Stephen P. J.
通讯作者:
Fancy, Stephen P. J.
影响因子:
6.4
作者:
Billiards, Saraid S.;Haynes, Robin L.;Kinney, Hannah C.
通讯作者:
Kinney, Hannah C.
影响因子:
4.7
作者:
Dai, H;Zhang, Z;Chen, Z
通讯作者:
Chen, Z